SCHEMBL30909276

SCHEMBL30909276

O=C(CCOc1ccccc1)Nc1ccc2occ(C3CCN4CCCC4C3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
NPC1 O15118 3/20 0.40
TP53 P04637 1/20 0.40
NAMPT P43490 1/20 0.40
MAPT P10636 5/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALOX15 P16050 1/20 0.40
CYP2D6 P10635 1/20 0.40
ROCK2 O75116 1/20 0.40
EGFR P00533 1/20 0.39
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39
DRD3 P35462 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8387125 1.00 RAB9A (0.42) RAB9AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL8386577 0.84 HTR1D (0.43) RAB9AALDH1A1CYP3A4SMN1; SMN2DRD2
SCHEMBL8384436 0.83 DRD2 (0.42) RAB9AALDH1A1NPC1MAPTSMN1; SMN2
SCHEMBL30908978 0.83 DRD2 (0.42) RAB9AALDH1A1NPC1MAPTSMN1; SMN2
SCHEMBL30908902 0.83 HTR2A (0.44) KMT2ATP53MAPTDRD2HTR2A
SCHEMBL8385565 0.83 HTR2A (0.44) KMT2ATP53MAPTDRD2HTR2A
SCHEMBL8381707 0.81 MEN1 (0.47) RAB9AALDH1A1KMT2AMEN1NPC1
SCHEMBL30908992 0.81 MEN1 (0.47) RAB9AALDH1A1KMT2AMEN1NPC1
SCHEMBL8548534 0.81 DRD2 (0.48) RAB9AALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL30908827 0.79 ACHE (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073845-A1 METHODS AND PHARMACOLOGICAL AGENTS FOR INCREASING EXPANSION, ENGRAFTMENT OR IMMUNE OUTPUT OF HUMAN HEMATOPOIETIC STEM CELLS IN TRANSPLANTATION AND DISEASE SETTINGS VALORISATION HSJ, LIMITED PARTNERSHIP (CA) 2024-04-11 WO disclosed